Find opportunity by dodging these OSD early-phase development mistakes

Explore the five key areas where mistakes in early decision-making can introduce long-term risk in OSD formulation development. Learn how to turn these risks into opportunities for creating optimal scalability, stability, and regulatory strategies. Don’t miss insights from Pharma Ignite and Thermo Fisher Scientific.

Read the article to discover:

The importance of understanding API complexity
Critical considerations when choosing the dosage form
Scalability and manufacturability approaches for successful scale-up
The pitfalls of underestimating regulatory and stability factors
The advantages of adopting a holistic approach to decision making

First Name

Last Name

Phone Number

Company

Job Title

What is your primary are of focus?

in Name Checkboxes

Are you currently involved in TCR and/or TCR-TCE discovery?

Checkboxes

By checking this box, I consent to receive communications from Thermo Fisher Scientific and Citeline , regarding their products, services, and events. Your information will be handled in accordance with Citeline and Thermo Fisher Scientific's Privacy Policies. You can withdraw your consent at any time by following the unsubscribe instructions provided in the communications.